First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.97 USD 6.2% Market Closed
Updated: Apr 24, 2024

ADC Therapeutics SA
Accounts Receivables

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

ADC Therapeutics SA
Accounts Receivables Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Accounts Receivables
$25.2m
CAGR 3-Years
N/A
CAGR 5-Years
163%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Accounts Receivables
CHf15m
CAGR 3-Years
111%
CAGR 5-Years
32%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Accounts Receivables
$200m
CAGR 3-Years
1 160%
CAGR 5-Years
357%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Accounts Receivables
CHf27.9m
CAGR 3-Years
47%
CAGR 5-Years
49%
CAGR 10-Years
22%
Idorsia Ltd
SIX:IDIA
Accounts Receivables
CHf4.3m
CAGR 3-Years
-10%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Accounts Receivables
CHf6.4m
CAGR 3-Years
84%
CAGR 5-Years
97%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Accounts Receivables?
Accounts Receivables
25.2m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Accounts Receivables amounts to 25.2m USD.

What is ADC Therapeutics SA's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
163%

Over the last year, the Accounts Receivables growth was -66%.